Spyre Therapeutics, Inc.
For the period ended May 29, 2025. Filed Jun 2, 2025.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 29, 2025 · Filed Jun 2, 2025
Use the contents to explore the available documents and sections.
SYRE$103.86+7.5%Stored close · as of Nov 6, 2026
Contents
Proposal No
Proposal No. 3
The Company’s stockholders ratified the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.